Higher-risk Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for Higher-risk Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS) [Phase 1]
Genmab announced a first-in-human Phase 1 trial of GEN3018 in relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic syn…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications [Phase 1, Phase 2]
A Phase 1/2 clinical trial of KPT-8602 (eltanexor) in participants with relapsed/refractory cancer indications completed, evaluating safety,…
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS [Phase 2]
Phase 2 trial evaluating nivolumab with oral cyclophosphamide for relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic s…